NJ State Employees Deferred Compensation Plan Invests $258,000 in Axon Enterprise, Inc. (NASDAQ:AXON)

NJ State Employees Deferred Compensation Plan bought a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 1,000 shares of the biotechnology company’s stock, valued at approximately $258,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. BKM Wealth Management LLC acquired a new position in Axon Enterprise in the fourth quarter valued at about $32,000. Key Financial Inc increased its stake in shares of Axon Enterprise by 367.6% in the fourth quarter. Key Financial Inc now owns 159 shares of the biotechnology company’s stock valued at $41,000 after buying an additional 125 shares in the last quarter. Lindbrook Capital LLC lifted its position in Axon Enterprise by 43.3% during the 4th quarter. Lindbrook Capital LLC now owns 172 shares of the biotechnology company’s stock worth $44,000 after buying an additional 52 shares in the last quarter. Rakuten Securities Inc. bought a new stake in Axon Enterprise during the 4th quarter worth about $48,000. Finally, Provence Wealth Management Group acquired a new stake in Axon Enterprise in the 3rd quarter valued at about $80,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Price Performance

NASDAQ:AXON traded up $1.99 during trading hours on Friday, hitting $308.23. 288,392 shares of the company’s stock traded hands, compared to its average volume of 466,619. The firm has a market cap of $23.26 billion, a P/E ratio of 135.19 and a beta of 0.93. The company has a quick ratio of 2.66, a current ratio of 3.00 and a debt-to-equity ratio of 0.42. Axon Enterprise, Inc. has a 52 week low of $175.37 and a 52 week high of $329.87. The business’s fifty day simple moving average is $302.78 and its two-hundred day simple moving average is $260.58.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.29. The business had revenue of $432.14 million during the quarter, compared to the consensus estimate of $418.97 million. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. On average, research analysts anticipate that Axon Enterprise, Inc. will post 2.44 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

AXON has been the subject of several recent research reports. Barclays boosted their price objective on Axon Enterprise from $296.00 to $308.00 and gave the stock an “overweight” rating in a report on Thursday, February 29th. StockNews.com downgraded Axon Enterprise from a “buy” rating to a “hold” rating in a report on Thursday, March 14th. William Blair reaffirmed an “outperform” rating on shares of Axon Enterprise in a research report on Wednesday. JMP Securities increased their target price on shares of Axon Enterprise from $250.00 to $285.00 and gave the stock a “market outperform” rating in a report on Tuesday, February 6th. Finally, Robert W. Baird lifted their price target on shares of Axon Enterprise from $260.00 to $300.00 and gave the company an “outperform” rating in a research note on Thursday, February 22nd. Two investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $314.91.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.